Risa Kagan, MD, on why the menopause transition is a critical window for bone loss and how women can preserve bone mass.
|Podcasts|December 21, 2022
Bonus episode: Alternatives to hysterectomy & uterine-preserving options for fibroids, part 1
Author(s)Lindsey Carr, Editor
This is part 1 of a 2-part series. In this bonus episode of Pap Talk, get an exclusive recap of Kimberly Kho, MD's presentation from AAGL 2022 on alternatives to hysterectomy and uterine-preserving options for fibroids.
Advertisement
Kimberly Kho, MD, MPH, is the vice chief of staff, associate chief of gynecology, and director of the Fellowship in Minimally Invasive Gynecologic Surgery at the University of Texas Southwestern Medical Center in Dallas, Texas.
Advertisement
Related to this article
This FAQ summarizes a Special Report discussion on testosterone pellet therapy in women and advice for hesitant prescribers.
In the premiere episode of Mind, Body, & the Pause, Soma Mandal, MD, is joined by Manisha Parulekar, MD, and Jocelyn Carlo, MD, FACOG, to discuss the stages of the menopause transition.
Mental health, bias, and trauma shape sexual health visits, and histories should assess function, not just risk, according to Sameena Rahman, MD.
This FAQ summarizes a Special Report discussion on off-label testosterone dosing, application, cost, and lab monitoring in women.
This FAQ summarizes a Special Report discussion on how two experts decide who is a candidate for testosterone therapy in women, from symptoms and context to hormone state vs age.
This FAQ summarizes a Special Report discussion of what the evidence does and does not establish about testosterone therapy in women.
Kanchi Chadha, MD, FACOG, MSCP, supports reconsidering MHT boxed warnings but says the FDA cited no study behind the change.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Risa Kagan, MD, on bone health across a woman's lifetime
2
FAQ: Where do testosterone pellets stand for women?
3
FAQ: What does the evidence show about testosterone in women?
4
HRSA opens $1 million funding to update women's preventive guidelines
5